127 related articles for article (PubMed ID: 18579174)
1. Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Tissue Cell; 2008 Dec; 40(6):405-10. PubMed ID: 18579174
[TBL] [Abstract][Full Text] [Related]
2. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.
Koda M; Sulkowska M; Wincewicz A; Kanczuga-Koda L; Musiatowicz B; Szymanska M; Sulkowski S
Ann N Y Acad Sci; 2007 Jan; 1095():90-8. PubMed ID: 17404022
[TBL] [Abstract][Full Text] [Related]
3. STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Famulski W; Sulkowski S
Gynecol Endocrinol; 2011 Aug; 27(8):536-40. PubMed ID: 21726118
[TBL] [Abstract][Full Text] [Related]
4. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
[TBL] [Abstract][Full Text] [Related]
5. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells.
Ren H; Jia L; Zhao T; Zhang H; Chen J; Yang S; Liu J; Yu M; Hao J
Cancer Lett; 2014 Nov; 354(1):172-80. PubMed ID: 25130171
[TBL] [Abstract][Full Text] [Related]
7. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
[TBL] [Abstract][Full Text] [Related]
8. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
[TBL] [Abstract][Full Text] [Related]
10. STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers.
Wincewicz A; Sulkowska M; Koda M; Leśniewicz T; Kanczuga-Koda L; Sulkowski S
Folia Histochem Cytobiol; 2007; 45(2):81-6. PubMed ID: 17597020
[TBL] [Abstract][Full Text] [Related]
11. Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer.
Koda M; Sulkowska M; Kanczuga-Koda L; Cascio S; Colucci G; Russo A; Surmacz E; Sulkowski S
Ann Oncol; 2007 Jun; 18 Suppl 6():vi116-9. PubMed ID: 17591803
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia contributes to development of recurrent endometrial carcinoma.
Pijnenborg JM; Wijnakker M; Hagelstein J; Delvoux B; Groothuis PG
Int J Gynecol Cancer; 2007; 17(4):897-904. PubMed ID: 17359291
[TBL] [Abstract][Full Text] [Related]
13. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S
Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between leptin receptor expression and PI3-K/Akt signaling pathway proteins immunostaining in endometrioid-type endometrial carcinomas.
Bogusiewicz M; Semczuk A; Gogacz M; Skomra D; Jakowicki JA; Rechberger T
Cancer Lett; 2006 Jul; 238(1):61-8. PubMed ID: 16085355
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
16. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.
Niu G; Briggs J; Deng J; Ma Y; Lee H; Kortylewski M; Kujawski M; Kay H; Cress WD; Jove R; Yu H
Mol Cancer Res; 2008 Jul; 6(7):1099-105. PubMed ID: 18644974
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
Abouhashem NS; Ibrahim DA; Mohamed AM
Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
[TBL] [Abstract][Full Text] [Related]
18. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
[TBL] [Abstract][Full Text] [Related]
19. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
20. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
